Lv4
740 积分 2022-04-17 加入
Opportunities and challenges of targeting cGAS–STING in cancer
30天前
已完结
GPR119 agonists: a promising approach for T2DM treatment? A SWOT analysis of GPR119
1个月前
已关闭
A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes
1个月前
已完结
Discovery of 1,4-Disubstituted Cyclohexene Analogues as Selective GPR119 Agonists for the Treatment of Type 2 Diabetes
1个月前
已完结
Structural insights into the activation of G protein-coupled receptor 119 by the agonist GSK1292263 and ligands selectivity among novel cannabinoid receptors
1个月前
已完结
Discovery of Fluoroalkenes as Dual Inhibitors of Diacylglycerol Kinases Alpha and Zeta (DGKα/ζ)
1个月前
已完结
化学药口服改静脉注射给药非临床安全性研究评价要点
1个月前
已完结
Discovery of MKP10241, a Novel Small Molecule Targeting the GPR119/Incretin Axis to Treat Metabolic Disorders
1个月前
已完结
NRF2 Activation Resolves Neuropathic Pain Via Dual Antioxidant And NaV1.7-Suppressive Mechanisms
1个月前
已关闭
Reducing hERG Inhibition in the Design of Potent and Bioavailable Indazole cGAS Inhibitors
2个月前
已完结
皖公网安备34019202002308
